Infertility Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Infertility Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The infertility drugs market is expected to register a CAGR of 6.5% over the forecast period (2022-2027).

The outbreak of COVID-19 adversely impacted the market. The disruption in the supply chain during COVID-19 and delay in delivery of essential products required for the manufacturing of infertility drugs imposed an adverse effect on the infertility drugs market. Furthermore, the suspension or delay of fertility treatments during COVID-19 across the globe also hindered the market growth. For instance, according to the study titled, " Suspension of fertility treatment during the COVID-19 pandemic: views, emotional reactions and psychological distress among women undergoing fertility treatment" published by the National Library of Medicine in April 2021, there was a suspension of fertility treatment during the initial phase of the pandemic which caused anxiety and psychological distress among women undergoing fertility treatment. Therefore, such instances indicate that the market witnessed slow growth during the pandemic.

The increasing adoption of a sedentary lifestyle by both men and women across the globe is one of the major factors contributing to the market growth over the forecast period. For instance, according to the report published by the National Center for Drug Abuse Statistics in 2021, around 60.0% of Americans increased their alcohol consumption during the COVID-19 lockdowns. Similarly, as per the report published by the World Health Organization in 2021, more than 300.0 million people in China were smokers which is around one-third of the world’s total population in 2021. Around 26.6% of adult smokers in China were of 15 years of age or above. The sedentary lifestyle is one of the major cause for hormonal imbalance, polycystic ovarian disease and weight issues which directly impacts the embryo, leading to infertility problems. Therefore, increasing adoption of sedentary lifestyle is one of the major drivers for the market.

However, stringent regulatory framework for product approval and expensive patented products are likely to impede the market growth over the forecast period.

Key Market TrendsFemale Infertility Drugs Segment is Expected to Witness Growth Over the Forecast Period

The female infertility drugs segment is expected to dominate the industry over the forecast period. The female infertility drugs are used to stimulate ovulation and are meant for treating women who are infertile or have ovulation disorder. Clomiphene citrate, Gonadotropins, Letrozole, Metformin, and Bromocriptine are some of the common female infertility drugs.

The increasing cases of infertility among females are one of the major drivers for the segment. For instance, as per the journal published by Singlecare in February 2022, around 30.0% of infertility cases can be attributed solely to females. Similarly, as per the report published by the World Health Organization in September 2020, 48.0 million couples and 186.0 million individuals are living with infertility across the globe. Furthermore, increasing cases of Polycystic Ovary Syndrome (PCOS) among women are also expected to trigger the segment growth. For instance, as per the study titled, "The Prevalence of Polycystic Ovary Syndrome" in December 2020, polycystic ovary syndrome (PCOS) is the major endocrinopathy among reproductive-aged women and it affects around 4.0%–20.0% of women of reproductive age globally. Therefore, such instances indicate that the demand for female infertility drugs will increase, thereby propelling the segment growth over the forecast period.

North America is Expected to Dominate the Infertility Drugs Market Over the Forecast Period

North America is expected to dominate the global infertility drugs market during the forecast period. This dominance is mainly owing to rising incidences of infertility problems, menopausal disorders, urinary infections, thyroid problems, endometriosis, and others due to busy lifestyles and a rise in stress among women. For instance, as per the report published by Statistics Canada in May 2022, fewer babies were born in Canada in 2020 due to the low fertility rate. It also reported that Canada's birth rate fell from 1.47 children per woman in 2019 to a record low of 1.40 children per woman in 2020. Moreover, Canada also witnessed the lowest number of births since 2007 and the greatest year-over-year decrease in births (-3.6%) since 1997. Therefore, such factors are anticipated to increase the sale of infertility drugs in this region, thereby surging the market growth.

High concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and an increasing number of infertility and PCOS cases in the United States are some of the factors driving the growth of the infertility drugs market in the country. For instance, as per the report published by the Centers for Disease Control and Prevention (CDC) in March 2020, PCOS is one of the most common causes of female infertility and it affects around 6.0% to 12.0% (approx 5.0 million) of women of reproductive age in the United States every year. Therefore such instances, indicate considerable growth of the market in the United States.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The global infertility drugs market is moderately competitive and consists of several major players. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Ferring Pharmaceuticals Inc., Merck KGaA, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Theramex, and Novartis AG among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.